Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
about
Medicinal importance of grapefruit juice and its interaction with various drugsPediatric Statin Administration: Navigating a Frontier with Limited DataThe effects of lacidipine on the steady/state plasma concentrations of simvastatin in healthy subjectsAdherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register studyMechanistic approaches to predicting oral drug absorption.Drug interactions and the statins.Rational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.Treatment of the elderly with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors: focus on drug interactions.Repurposing Drugs in Oncology (ReDO)-itraconazole as an anti-cancer agent.Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era.Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.Fluvastatin and fluvastatin extended release: a clinical and safety profile.Drug-drug interactions of antifungal agents and implications for patient care.Role of P-glycoprotein in statin drug interactions.Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.Computing with evidence Part II: An evidential approach to predicting metabolic drug-drug interactions.Does simvastatin cause more myotoxicity compared with other statins?Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.Best practices for the use of itraconazole as a replacement for ketoconazole in drug-drug interaction studies.Drug-drug interactions that interfere with statin metabolism.Use of nystatin and chlorhexidine in oral medicine: Properties, indications and pitfalls with focus on geriatric patients.Simvastatin-associated rhabdomyolysis after coadministration of macrolide antibiotics in two patients.Drug interactions due to cytochrome P450.Fluvastatin delays propagation of viral infection in isolated rat FDB myofibers but does not affect exocytic membrane trafficking.Mechanism-based pharmacokinetic modeling to evaluate transporter-enzyme interplay in drug interactions and pharmacogenetics of glyburide.Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects.Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin.Simvastatin-fluconazole causing rhabdomyolysis.Dose dependency of fluvastatin pharmacokinetics in serum determined by reversed phase HPLC.Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.Rhabdomyolysis after concomitant use of cyclosporine, simvastatin, gemfibrozil, and itraconazole.Antifungal activity of fluconazole in combination with lovastatin and their effects on gene expression in the ergosterol and prenylation pathways in Candida albicans.Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.Pharmacokinetics and bioequivalence study of two tablet formulations of lovastatin in healthy volunteers.Pharmacokinetic Drug Interactions of Apatinib With Rifampin and Itraconazole.
P2860
Q21245902-043FF01F-5073-4F74-A201-E693974CEE2DQ28068014-142034D4-449D-4E3A-9B8C-9949D071C01CQ28361017-ABD2F873-A9DD-4B65-896A-0C076C456BB6Q28535157-35097DA1-0E89-4B30-9171-E63BA181B5B5Q33432960-B972B36B-C495-4EA8-BF1F-C6B13D236C7AQ33786019-02EDB135-FD2C-495B-AEAD-76302D0B6053Q34233142-F1265A63-4745-464D-B913-98284FDFB463Q34389584-34A9BD5D-22A5-4C50-BC0F-928338DEA84BQ34474583-B06EA843-D9AD-40B2-8A69-84D97E34C466Q35194386-AC4AE2AD-EFA5-4627-9FBE-E2E5FEDB3991Q35827146-BC958016-5522-4EFC-8496-F5868D19CA47Q35879055-4BA559E5-F1A9-40D7-9CC9-AC1678874C02Q36283721-5D7546EF-8DC8-47A0-80AE-D5CE2C8EAF99Q36634221-276E5B89-7DAB-429E-B878-E25DE42E661BQ36801821-7565CB79-BBC7-4F0E-9602-07CD013E8AD4Q37399440-8EEF4CC2-922A-4DE8-9C5B-A405606FEADFQ37440022-078D0B79-1E00-4B8A-B373-0B44687BE091Q37634190-44D8AF7F-20F1-4461-8E06-F6F4FDA24392Q37945308-EDC086ED-3AC4-4C27-AAA0-662B858FB662Q37986145-6DB84FD9-17F0-4A02-8067-09CC99931F4DQ38049379-0AC70B94-5F3D-463D-ADDC-417A6327BAEFQ38516237-3B06C7B1-4994-4A5A-841E-5169AA6E028EQ38522299-C84FCACE-4CC4-499D-B6A5-87458C020382Q39337642-E088D90D-A7D0-4E0F-AE27-2186B9776742Q40230832-A0DFCA55-3BCE-4FAE-947C-3E66B5F16728Q40562160-D5516420-C3AE-4D41-8F40-D67A16950665Q41132008-D4299FEA-8341-4420-858C-BD8B1A3C66EDQ41150870-E0258EA2-3E69-4298-9E18-32B31739C34BQ41871830-5E4EF67E-C329-42DC-A68F-10CD9286C10DQ41896286-00066225-08CC-480A-B044-2E09D06691ADQ42166140-1F461B43-3E1A-4C43-8FD3-0C13A228FE7FQ43710353-45737A53-B4AC-4425-A80E-0DB3F978D7AAQ43926585-A7D706CA-4BCD-4C2F-89ED-DEE67285BB3AQ43972185-66DCA78B-18FF-486D-B519-1D0DB99B75E8Q44678465-45C4FEC2-3956-43A9-81A3-54599954F6B4Q44803518-6B0151B6-FBC2-4E2D-8BC7-FE168FD333A2Q45069532-312CCFDB-AA5A-4EB2-9CFF-DE511563C2CCQ45230084-CF5658C0-7D24-49B6-B601-4D8C6C30ECA9Q46739223-61A9F851-463B-4692-8A1A-E15DFA8A1EA3Q47885966-3F2387A1-EAB4-4A57-80CA-1528785C5596
P2860
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@ast
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@en
type
label
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@ast
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@en
prefLabel
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@ast
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@en
P2093
P2860
P1476
Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin
@en
P2093
K T Kivistö
P J Neuvonen
P2860
P356
10.1046/J.1365-2125.1998.00034.X
P407
P577
1998-07-01T00:00:00Z